Have a personal or library account? Click to login
Genetic Diagnosis in Movement Disorders. Use of Whole-Exome Sequencing in Clinical Practice Cover

Genetic Diagnosis in Movement Disorders. Use of Whole-Exome Sequencing in Clinical Practice

Tremor and Other Hyperkinetic Movements
Volume 12 (2022): Issue 1
By: Patricio Millar Vernetti,  María Agustina Ruiz Yanzi,  Malco Rossi and  Marcelo Merello  
Open Access
|Apr 2022

References

  1. 1Bonifati V. Will New Genetic Techniques Like Exome Sequencing and Others Obviate the Need for Clinical Expertise? Yes. Movement disorders clinical practice. 2017 Jan; 4(1): 36. DOI: 10.1002/mdc3.12438
    Back to article
  2. 2Sethi KD, Lang AE. Will new genetic techniques like exome sequencing obviate the need for clinical expertise? No. Movement disorders clinical practice. 2017 Jan; 4(1): 39. DOI: 10.1002/mdc3.12443
    Back to article
  3. 3Bertier G, Hétu M, Joly Y. Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users’ views. BMC medical genomics. 2016 Dec; 9(1): 1–2. DOI: 10.1186/s12920-016-0213-6
    Back to article
  4. 4Klein CJ, Foroud TM. Neurology individualized medicine: when to use next-generation sequencing panels. InMayo Clinic Proceedings. 2017 Feb 1; 92(2): 292–305. Elsevier. DOI: 10.1016/j.mayocp.2016.09.008
    Back to article
  5. 5Trujillano D, Bertoli-Avella AM, Kandaswamy KK, Weiss ME, Köster J, Marais A, Paknia O, Schröder R, Garcia-Aznar JM, Werber M, Brandau O. Clinical exome sequencing: results from 2819 samples reflecting 1000 families. European Journal of Human Genetics. 2017 Feb; 25(2): 176–82. DOI: 10.1038/ejhg.2016.146
    Back to article
  6. 6Krenn M, Wagner M, Strom TM, Auff E, Zimprich F. Diagnostic yield of whole-exome sequencing in neurological diseases. Journal of the Neurological Sciences. 2017 Oct 15; 381: 160. DOI: 10.1016/j.jns.2017.08.468
    Back to article
  7. 7Stavropoulos DJ, Merico D, Jobling R, Bowdin S, Monfared N, Thiruvahindrapuram B, Nalpathamkalam T, Pellecchia G, Yuen RK, Szego MJ, Hayeems RZ. Whole-genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine. NPJ genomic medicine. 2016 Jan 13; 1(1): 1–9.
    Back to article
  8. 8Valencia CA, Husami A, Holle J, Johnson JA, Qian Y, Mathur A, Wei C, Indugula SR, Zou F, Meng H, Wang L. Clinical impact and cost-effectiveness of whole exome sequencing as a diagnostic tool: a pediatric center’s experience. Frontiers in pediatrics. 2015 Aug 3; 3: 67. DOI: 10.3389/fped.2015.00067
    Back to article
  9. 9Vissers LE, Van Nimwegen KJ, Schieving JH, Kamsteeg EJ, Kleefstra T, Yntema HG, Pfundt R, Van Der Wilt GJ, Krabbenborg L, Brunner HG, Van Der Burg S. A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology. Genetics in Medicine. 2017 Sep; 19(9): 1055–63. DOI: 10.1038/gim.2017.1
    Back to article
  10. 10Kuperberg M, Lev D, Blumkin L, Zerem A, Ginsberg M, Linder I, Carmi N, Kivity S, Lerman-Sagie T, Leshinsky-Silver E. Utility of whole exome sequencing for genetic diagnosis of previously undiagnosed pediatric neurology patients. Journal of child neurology. 2016 Dec; 31(14): 1534–9. DOI: 10.1177/0883073816664836
    Back to article
  11. 11Montaut S, Tranchant C, Drouot N, Rudolf G, Guissart C, Tarabeux J, Stemmelen T, Velt A, Fourrage C, Nitschké P, Gerard B. Assessment of a targeted gene panel for identification of genes associated with movement disorders. JAMA neurology. 2018 Oct 1; 75(10): 1234–45. DOI: 10.1001/jamaneurol.2018.1478
    Back to article
  12. 12Marrodan M, Rossi M, Merello M. Rapid-onset dystonia-parkinsonism preceded by a single episode of subacute persisting hemiparesis: Expanding the ATP1A3-related disorders phenotype. Journal of the neurological sciences. 2018 Sep 15; 392: 44–5. DOI: 10.1016/j.jns.2018.07.002
    Back to article
  13. 13Salen G, Steiner RD. Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX). Journal of inherited metabolic disease. 2017 Nov; 40(6): 771–81. DOI: 10.1007/s10545-017-0093-8
    Back to article
  14. 14Manes M, Alberici A, Di Gregorio E, Boccone L, Premi E, Mitro N, Pasolini MP, Pani C, Paghera B, Orsi L, Costanzi C. Long-term efficacy of docosahexaenoic acid (DHA) for spinocerebellar ataxia 38 (SCA38) treatment: an open label extension study. Parkinsonism & related disorders. 2019 Jun 1; 63: 191–4. DOI: 10.1016/j.parkreldis.2019.02.040
    Back to article
  15. 15Martínez-Monseny AF, Bolasell M, Callejón-Póo L, Cuadras D, Freniche V, Itzep DC, Gassiot S, Arango P, Casas-Alba D, de la Morena E, Corral J. AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG). Annals of neurology. 2019 May; 85(5): 740–51. DOI: 10.1002/ana.25457
    Back to article
  16. 16Vernetti PM, Rossi M, Merello M. Parkin pleiotropy: extremely atypical phenotypes in patients with compound heterozygous mutations. Tremor and Other Hyperkinetic Movements. 2020; 10. DOI: 10.5334/tohm.55
    Back to article
  17. 17Rossi M, Escobar AM, Ameghino L, Merello M. Expanding the phenotype of phosphomannomutase-2 gene congenital disorder of glycosylation: Cervical dystonia. Journal of the neurological sciences. 2017 Jul 15; 378: 52–4. DOI: 10.1016/j.jns.2017.04.037
    Back to article
  18. 18Rossi M, Escobar AM, Radrizzani M, Tenembaum S, Perandones C, Merello M. Dystonia in a Patient with Autosomal-Dominant Progressive External Ophthalmoplegia Type 1 Caused by Mutation in the POLG Gene. Movement disorders clinical practice. 2017 Mar; 4(2): 266. DOI: 10.1002/mdc3.12397
    Back to article
  19. 19Zech M, Lam DD, Winkelmann J. Update on KMT2B-related dystonia. Current neurology and neuroscience reports. 2019 Nov; 19(11): 1–1. DOI: 10.1007/s11910-019-1007-y
    Back to article
  20. 20Stumpf JD, Saneto RP, Copeland WC. Clinical and molecular features of POLG-related mitochondrial disease. Cold Spring Harbor perspectives in biology. 2013 Apr 1; 5(4): a011395. DOI: 10.1101/cshperspect.a011395
    Back to article
  21. 21Wassenberg T, Molero-Luis M, Jeltsch K, Hoffmann GF, Assmann B, Blau N, Garcia-Cazorla A, Artuch R, Pons R, Pearson TS, Leuzzi V. Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency. Orphanet journal of rare diseases. 2017 Dec; 12(1): 1–21. DOI: 10.1186/s13023-016-0522-z
    Back to article
  22. 22Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998; 392(6676): 605–6089560156. DOI: 10.1038/33416
    Back to article
  23. 23de Oliveira LM, Barbosa ER, Aquino CC, Munhoz RP, Fasano A, Cury RG. Deep brain stimulation in patients with mutations in Parkinson’s disease–related genes: a systematic review. Movement disorders clinical practice. 2019 Jun; 6(5): 359–68. DOI: 10.1002/mdc3.12795
    Back to article
  24. 24Masoud M, Prange L, Wuchich J, Hunanyan A, Mikati MA. Diagnosis and treatment of alternating hemiplegia of childhood. Current treatment options in neurology. 2017 Feb 1; 19(2): 8. DOI: 10.1007/s11940-017-0444-7
    Back to article
  25. 25Groen JL, Ritz K, Contarino MF, van de Warrenburg BP, Aramideh M, Foncke EM, van Hilten JJ, Schuurman PR, Speelman JD, Koelman JH, de Bie RM. DYT6 dystonia: mutation screening, phenotype, and response to deep brain stimulation. Movement disorders. 2010 Oct 30; 25(14): 2420–7. DOI: 10.1002/mds.23285
    Back to article
DOI: https://doi.org/10.5334/tohm.678 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Dec 10, 2021
Accepted on: Mar 1, 2022
Published on: Apr 20, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
WES,
whole-exome sequencing,
genetics,
diagnosis,
controversies

© 2022 Patricio Millar Vernetti, María Agustina Ruiz Yanzi, Malco Rossi, Marcelo Merello, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 12 (2022): Issue 1Next article